通过食品和药物管理不良事件报告系统评估戒药综合征风险:全面的不成比例分析
Zheng Zhang1, Qianzhi Yang1, Minghao Chen1
1Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
Frontiers in pharmacology
|July 25, 2024
概括
这项研究使用食品和药物管理局不良事件报告系统 (FAERS) 识别了与戒断综合征相关的药物. 阿片类药物,抗抑郁药和抗焦虑药最常与戒断症状有关.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 临床药理学 临床药理学
背景情况:
- 药物戒断综合征是一个重要的临床问题.
- 识别相关药物对于患者安全至关重要.
研究的目的:
- 为了识别与戒药综合征相关的药物.
- 估计这些药物导致戒断的风险.
主要方法:
- 利用了来自食品和药物管理局不良事件报告系统 (FAERS) (2004-2023) 的数据.
- 使用不成比例分析,包括赔率比率 (ROR),以检测不良事件信号.
主要成果:
- 分析了94,370份关于戒断综合征的报告.
- 确定了29种药物,具有积极的戒断综合征信号.
- 最重要的药物类别包括阿片类药物,抗抑郁药物和抗焦虑药物.
结论:
- 从FAERS数据中生成了与戒断综合征相关的药物的全面列表.
- 研究结果支持医疗保健专业人员识别和管理戒断症状.
相关概念视频
Pharmacovigilance
810
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
810
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Assessment of the Gastrointestinal System I: Subjective Data
165
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
165
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Drug Dependence
992
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
992
Drug Administration and Therapy Phases: Overview
429
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
429


